

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washingto⦠read more
Healthcare
Biotechnology
5 years
USD
Exclusive to Premium users
$1.51
Price0.00%
$0.00
$190.721m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$9.600m
-
1y CAGR-
3y CAGR-
5y CAGR-$65.686m
+7.2%
1y CAGR-4.6%
3y CAGR-7.2%
5y CAGR-$0.52
+7.1%
1y CAGR-4.5%
3y CAGR+2.5%
5y CAGR$181.094m
$213.189m
Assets$32.095m
Liabilities$28.183m
Debt13.2%
-0.4x
Debt to EBITDA-$56.287m
+8.1%
1y CAGR-5.8%
3y CAGR-8.4%
5y CAGR